GENiusVac, a novel immunotherapeutic strategy based on a potent plasmacytoid dendritic cell (pDC) line

被引：0
|
作者：
Aspord, Caroline
Julie, Charles
Marie-Therese, Leccia
Jean-Paul, Molens
Laurence, Chaperot
Joel, Plumas
机构：
[1] Inserm 823, Paris, France
[2] CHU Grenoble, Grenoble, France
来源：
BULLETIN DU CANCER | 2009年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25
引用
收藏
页码：S22 / S23
页数：2
相关论文
共 50 条
  • [21] A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
    Takahiro Maeda
    Kenn Murata
    Takuya Fukushima
    Kazuyuki Sugahara
    Kazuto Tsuruda
    Masanobu Anami
    Yasuyuki Onimaru
    Kunihiro Tsukasaki
    Masao Tomonaga
    Ryouzou Moriuchi
    Hiroo Hasegawa
    Yasuaki Yamada
    Shimeru Kamihira
    International Journal of Hematology, 2005, 81 : 148 - 154
  • [22] A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma
    Maeda, T
    Murata, K
    Fukushima, T
    Sugahara, K
    Tsuruda, K
    Anami, M
    Onimaru, Y
    Tsukasaki, K
    Tomonaga, M
    Moriuchi, R
    Hasegawa, H
    Yamada, Y
    Kamihira, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 81 (02) : 148 - 154
  • [23] Promoting ER stress in a plasmacytoid dendritic cell line drives fibroblast activation
    Beatriz H. Ferreira
    Inês S. Silva
    Andreia Mendes
    Fátima Leite-Pinheiro
    Adrienne W. Paton
    James C. Paton
    Iola F. Duarte
    Philippe Pierre
    Catarina R. Almeida
    Cell Communication and Signaling, 23 (1)
  • [24] M-CSF: a novel plasmacytoid and conventional dendritic cell poietin
    Fancke, Ben
    Suter, Mark
    Hochrein, Hubertus
    O'Keeffe, Meredith
    BLOOD, 2008, 111 (01) : 150 - 159
  • [25] Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Minas P. Economides
    David Rizzieri
    Naveen Pemmaraju
    Current Hematologic Malignancy Reports, 2019, 14 : 515 - 522
  • [26] A leukemic plasmacytoid dendritic cell line (PMDC05) as potent antigen presenting cells for anti-tumor cellular immunothrerapy
    Yamahira, Akie
    Narita, Miwako
    Nakamura, Takeshi
    Watanabe, Norihiro
    Kaji, Masami
    Taniguchi, Tomoyo
    Hashimoto, Shigeo
    Takahashi, Masuhiro
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [27] Tagraxofusp as first-line treatment for blastic plasmacytoid dendritic cell neoplasm
    Diaz Acedo, Rocio
    Dominguez Munoz, Maria Angeles
    Navajas Laguna, Clara
    Morales Camacho, Rosario
    Simon Pilo, Isabel
    Calama Ruiz-Mateos, Virgilio Pablo
    Yebenes Ramirez, Manuel
    Vahi Sanchez de Medina, Maria
    Artacho Criado, Silvia
    Rodriguez Perez, Aitana
    Couto Caro, Maria Carmen
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1762 - 1764
  • [28] Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Economides, Minas P.
    Rizzieri, David
    Pemmaraju, Naveen
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (06) : 515 - 522
  • [29] Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report
    Grushchak, Solomiya
    Joy, Cossette
    Gray, Arielle
    Opel, Dan
    Speiser, Jodi
    Reserva, Jeave
    Tung, Rebecca
    Smith, Scott E.
    MEDICINE, 2017, 96 (51)
  • [30] NOVEL STRATEGY FOR DESIGNING AND OPTIMIZING OF DENDRITIC - CELL - BASED ANTICANCER VACCINE
    Khranovska, N.
    Potebnia, G. P.
    Skachkova, O. V.
    Tanasienko, O. A.
    Svergun, N. M.
    Sitko, V. V.
    Fedorchuk, O. G.
    Niculina, V. V.
    ANNALS OF ONCOLOGY, 2012, 23 : 536 - 536
12345